HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2.

AbstractBACKGROUND:
The literature on neurological manifestations in COVID-19 patients has been rapidly increasing with the pandemic. However, data on CNS inflammatory disorders in COVID-19 are still evolving. We performed a literature review of CNS inflammatory disorders associated with coronavirus disease-2019 (COVID-19).
METHODS:
We screened all articles resulting from a search of PubMed, Google Scholar and Scopus, using the keywords; "SARS-CoV-2 and neurological complication", "SARS-CoV-2 and CNS Complication" looking for reports of transverse myelitis, longitudinally extensive transverse myelitis, neuromyelitis optica, myelitis, Myelin Oligodendrocyte Glycoprotein Antibody Disorder (MOGAD), Acute Disseminated Encephalomyelitis (ADEM), Acute Hemorrhagic Necrotizing Encephalitis/Acute Hemorrhagic Leukoencephalitis (AHNE/AHLE), Cytotoxic lesion of the Corpus Callosum/Mild Encephalopathy Reversible Splenium Lesion(CLOCC/MERS) and Optic neuritis published between December 01, 2019 and March 15, 2021.
RESULTS:
Our literature search revealed 43 patients meeting the diagnosis of myelitis, including Transverse Myelitis, ADEM, AHNE/AHLE or CLOCC/MERS and Optic neuritis. Acute myelitis was most commonly associated with non-severe COVID-19 and all reported cases of AHNE/AHLE had severe COVID-19 infection. Based on IDSA/ATS criteria of either requiring vasopressor for septic shock or mechanical ventilation, 49% (n = 18) patients were considered to have a severe COVID infection. There were 7 (n = 19%) fatalities.
CONCLUSION:
To our knowledge, this is among the first reviews that includes the clinical features, neuroimaging, CSF findings and outcomes in COVID-19-associated CNS inflammatory disorders. Our observational review study reveals that although rare, myelitis, ADEM, AHNE and CLOCC can be associated with COVID-19 infection. Further studies using MRI imaging and CSF analysis in early diagnosis and intervention of these disorders are warranted.
AuthorsShitiz Sriwastava, Medha Tandon, Sanjiti Podury, Apoorv Prasad, Sijin Wen, Garret Guthrie, Mihir Kakara, Shruti Jaiswal, Roshan Subedi, Mahmoud Elkhooly, Robert P Lisak
JournalJournal of neurology (J Neurol) Vol. 268 Issue 12 Pg. 4448-4478 (Dec 2021) ISSN: 1432-1459 [Electronic] Germany
PMID34009454 (Publication Type: Journal Article, Review)
Copyright© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
Chemical References
  • Myelin-Oligodendrocyte Glycoprotein
Topics
  • COVID-19 (cerebrospinal fluid, diagnostic imaging)
  • Central Nervous System Diseases (cerebrospinal fluid, virology)
  • Humans
  • Myelin-Oligodendrocyte Glycoprotein
  • Myelitis, Transverse (diagnostic imaging, virology)
  • Neuroimaging
  • Observational Studies as Topic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: